Chrome Extension
WeChat Mini Program
Use on ChatGLM

Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries.

Roberto José Pessoa de Magalhães Filho,Edvan Crusoe,Eloisa Riva,Willen Bujan,Guilhermo Conte, Juan Ramon Navarro Cabrera, Diana Katerine Garcia,Guilhermo Quintero Vega,Jose Macias, Jose Willian Oliveros Alvear, Mercedes Royg, Lidiane Andino Neves, Jose Luis Lopez Dopico, German Espino, Douglas Rosales Ortiz,Zurelis Socarra,Dorotea Fantl,Guillermo J Ruiz-Arguelles,Angelo Maiolino,Vania Tietsche de Moraes Hungria, Jean-Luc Harousseau,Brian Durie

Clinical Lymphoma Myeloma and Leukemia(2019)

Cited 16|Views32
No score
Abstract
Our data indicates that bortezomib and transplant are still an unmet medical necessity in public systems. In the complex puzzle of myeloma drug access in LATAMC, important issues, such as the adjustment of disparities between health systems, the incorporation of new drugs with an economic cost-effectiveness view, and the re-establishment of essential old drugs, can be a platform to the future.
More
Translated text
Key words
Access,Health care systems,Latin America Countries,Multiple Myeloma,New agents
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined